Saudi Arabia Army Report issue

Government Phase 2 Phase 3 Phase 4
Founded: Saudi Arabia (1744)

Organization Overview

First Clinical Trial
2013
NCT01937234
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Armed Forces Hospitals, Southern Region, Saudi Arabia | Ministry of National Guard | Postpartum ward of Armed Forces Hospital, Southern Region. Khamis Mushait, Asir, Saudi Arabia, 101

Active Ingredients

Drugs in Phase 4 Trials (1)

metoclopramide (reglan) (1 trial)

Drugs in Phase 3 Trials (2)

scopolamine (transderm scop) (1 trial)

sodium chloride (1 trial)

Drugs in Phase 2 Trials (4)

amoxicillin (1 trial)

clarithromycin (biaxin) (1 trial)

esomeprazole (nexium) (1 trial)

nigella sativa (1 trial)

Drugs in Other Trials (1)

coffee (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dyspepsia (Phase 2)

Gastritis (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 8